F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim ...Middle East

New Investment from Forbion and Sofinnova Partners MANCHESTER, England, Aug. 4, 2022 /PRNewswire/ -- F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening rare fungal infections with a high unmet medical...

Hence then, the article about f2g announces 70 million financing to advance development and commercialization of new antifungal agent olorofim was published today ( Thursday 04/08/2022 - 10:12 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim )

Also on site :

• Another Weight Loss Surgery and a Wedding Bombshell: Spoilers From '1000-Lb Sisters' Season 8 Episode 2
• Trump-Iran latest: President threatens ‘very strong action’ if protesters are hanged after forced confessions
• Saks Global Secures $1.75 Billion of Committed Capital and Announces Return of Industry Veterans to Advance Transformation of Iconic Luxury Portfolio